ClinicalTrials.gg
Not yet recruitingNCT07706998Updated Jul 16, 2026

Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis

An interventional study of An iLN interactive teaching platform and PPT in Learning, sponsored by Nanjing University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Nanjing University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 96 studies in Lupus Nephritis with a site in China — 43 open to participants now, 46 under way, 8 of them phase 3. Lupus Nephritis · China.

Planned enrollment
45th of 88
50 · median 51
Started
2026
with 10 others
No phase
16 of 96
6 open now
Primary completion
2026-12
later than 16 of 45 live
Registered
92nd of 96
by date

Among the 96 studies in Lupus Nephritis with a site in China, this one is the 45th largest by planned enrollment of the 88 interventional ones that give a count, is one of 11 that started in 2026, is one of 16 with no phase, reaches primary completion later than 16 of the 45 other live ones, and was the 92nd registered.

Lupus Nephritis

343 studies on the registry are indexed under Lupus Nephritis; 137 are open to participants now.

Browse Lupus Nephritis studies →

Open to participants now

43 of the 96 studies in Lupus Nephritis with a site in China are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 89 Lupus Nephritis studies recruiting now, 30 (34%) set no upper age limit and 52 (58%) stop at 75 or younger; 30 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Lupus Nephritis with a site in China, or all of them as a file.
02

Study summary

Aim:

To evaluate the application effect of the teaching platform iLN in the teaching of lupus nephritis, aiming to provide practical experience and evidence-based support for the implementation of generative AI technology in professional medical education.

Method:

Based on the DeepSeek large language model, the investigators developed "iLN" - an interactive teaching platform for lupus nephritis. This platform integrates the latest authoritative textbooks, clinical guidelines, pathological atlases, and real clinical cases, and includes seven core modules, such as "case interaction", "knowledge teaching", and "AI question answering". The investigators conducted a randomized controlled trial (RCT) on 50 fourth-year undergraduate students from Nanjing University School of Medicine to evaluate the effectiveness of the iLN platform compared to traditional teaching methods. The teaching effect was evaluated through objective test scores and questionnaires about student satisfaction and platform usability.

Read the detailed description

Artificial Intelligence (AI) technology is reshaping the landscape of medical education with unprecedented depth and breadth. From early rule-based teaching expert systems to the current generation of Generative AI (GAI) systems like ChatGPT and DeepSeek, the continuous evolution of technology has not only greatly enriched teaching methods but also fundamentally changed the ways knowledge is acquired, disseminated, and evaluated. Internationally, Generative AI (GAI) has been widely applied in creating virtual cases, constructing clinical simulation scenarios, assisting medical writing, and providing personalized learning plans for medical students. However, there are almost no dedicated large language model (GAI) teaching applications specifically for lupus nephritis (LN) worldwide. As the most common severe organ complication of systemic lupus erythematosus (SLE), LN affects approximately 50% to 70% of SLE patients with kidney involvement. Its diagnosis and treatment involve multiple complex processes, including the identification of clinical manifestations, the interpretation of immune markers, the assessment of renal pathological types, the quantification of disease activity, and the formulation of personalized treatment plans. All of these place extremely high demands on the knowledge integration and clinical reasoning skills of medical students. The traditional LN teaching model mainly relies on theoretical classroom lectures and is supplemented by static pathological image presentations. Some scholars have introduced problem-based learning (PBL) teaching models and integrated ideological and political education, but there are still significant deficiencies: (1) Knowledge update lag - In the field of LN, new diagnostic standards (such as the 2019 EULAR/ACR systemic lupus erythematosus classification criteria), new pathological classifications (such as the 2018 ISN/RPS revised version), and new drug treatment regimens (such as belimumab) are constantly emerging, while the textbook revision cycle is relatively long, making it difficult for students to obtain the latest knowledge in a timely manner; (2) Lack of personalized teaching - Facing students with varying levels of basic knowledge, teachers find it difficult to meet the needs of different learning paces; students with weak foundations have difficulty understanding complex pathological mechanisms, while those with solid foundations may find the content too simplistic; (3) Insufficient clinical reasoning training - Traditional classrooms lack real clinical scenario simulations, and students listen passively rather than actively exploring, making it difficult for them to establish a complete clinical reasoning chain from "symptoms - signs - laboratory tests - pathology - diagnosis - treatment". In this context, building a GAI-assisted teaching platform specifically designed for LN teaching, fully leveraging the personalized interaction, dynamic content generation, and intelligent assessment capabilities of AI, is of great significance for teaching reform and innovation.

In this study, the investigators constructed an iLN interactive teaching platform for lupus nephritis based on the DeepSeek large language model and by integrating the latest authoritative textbooks, guidelines, and clinical pathology materials. Through a randomized controlled teaching trial, the investigators systematically evaluated the application effect of this platform in LN teaching, aiming to provide practical experience and evidence-based support for the implementation of GAI technology in specialized medical education.

03

Conditions studied

  • Learning

Browse trials for

Keywords

  • Generative artificial intelligence
  • DeepSeek
  • Lupus nephritis
  • Medical education
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • As a student majoring in clinical medicine
  • Volunteering to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Inability to understand, read, or communicate in Chinese
  • Failure to participate in any stage of the study (e.g. in-class education session, or post-test)
  • Requesting withdrawal from the study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    GAI-assisted teaching group

    GAI-assisted teaching group: Students used various platform modules for self-directed learning under the instructor's guidance: (1) In the "Case Interaction" module, students interacted with three virtual cases by inputting natural language questions (e.g., "Does the patient have edema?", "What is the patient's proteinuria level?", "What are the light microscopy results of the renal biopsy?"). The platform automatically determines the question type and provides the corresponding information, while the visualized patient model on the right side simultaneously highlights the affected systems already identified, and the case information acquisition progress bar is updated dynamically; (2) When students encounter difficulties, they can invoke DeepSeek in real time for immediate answers through the "AI Q\&A" module; (3) After completing case interactions, students proactively summarized the history characteristics, with the instructor providing supplementary input; (4) The instructor guided

    Device: An iLN interactive teaching platform

  • Other
    Traditional teaching group

    Traditional teaching group: Adopted the traditional PowerPoint (PPT) lecture mode. The instructor used uniformly prepared PPT courseware to sequentially lecture on the SLE overview, LN clinical manifestations, laboratory tests, pathological classification, diagnostic criteria, treatment plans, and prognosis evaluation. The courseware included static pathological and clinical manifestation images.

    Other: PPT

Interventions

  • DeviceAn iLN interactive teaching platform

    An iLN interactive teaching platform for lupus nephritis based on the DeepSeek large language model and by integrating the latest authoritative textbooks, guidelines, and clinical pathology materials.

  • OtherPPT

    Adopted the traditional PowerPoint (PPT) lecture mode. The instructor used uniformly prepared PPT courseware to sequentially lecture on the SLE overview, LN clinical manifestations, laboratory tests, pathological classification, diagnostic criteria, treatment plans, and prognosis evaluation. The courseware included static pathological and clinical manifestation images.

06

What researchers measure

Primary outcomes

  1. Objective Test Scores

    Unified in-class objective test (20 multiple-choice questions, 5 points each, 100 points total),the higher the score, the better the performance.

    Time frame: On the day of the end of the teaching session within 30 minutes after teaching session

Secondary outcomes

  1. Questionnaire Survey

    Students in the GAI group filled out the questionnaire on the iLN platform, including overall satisfaction (satisfied/dissatisfied), and gave scores (from 1 to 5) on 12 dimensions such as the platform's interest, teaching novelty, content clarity, interface design, and learning effect improvement. They also submitted open-ended suggestions for improvement.

    Time frame: On the day of the end of the teaching session within 60 minutes after teaching session.

07

Study locations

1 site
08

References and documents

Publications

  • Lin Y, Luo Z, Ye Z, Zhong N, Zhao L, Zhang L, Li X, Chen Z, Chen Y. Applications, Challenges, and Prospects of Generative Artificial Intelligence Empowering Medical Education: Scoping Review. JMIR Med Educ. 2025 Oct 23;11:e71125. doi: 10.2196/71125. PubMed 41128430 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2026; primary completion for Dec 2026, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2026
First posted
Jul 16, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07706998
Lead sponsor
Nanjing University
Responsible party
Wang Ju'an (Principal Investigator, Nanjing University) — Principal investigator
First posted
Jul 16, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 16, 2026

Study contacts

Hao Bao, Doctor.
Contact
bhao@nju.edu.cn
86-15062213937

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion